Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.

A major advance in understanding human immunodeficiency virus (HIV) biology was the discovery that the beta-chemokines MIP-1 alpha (macrophage inflammatory protein-1 alpha), MIP-1 beta (macrophage inflammatory protein-1 beta) and RANTES (regulated on activation, normal T-cell expressed and secreted)...

Full description

Bibliographic Details
Main Authors: Price, D, Sewell, A, Dong, T, Tan, R, Goulder, P, Rowland-Jones, S, Phillips, R
Format: Journal article
Language:English
Published: Elsevier 1998
_version_ 1797103953981210624
author Price, D
Sewell, A
Dong, T
Tan, R
Goulder, P
Rowland-Jones, S
Phillips, R
author_facet Price, D
Sewell, A
Dong, T
Tan, R
Goulder, P
Rowland-Jones, S
Phillips, R
author_sort Price, D
collection OXFORD
description A major advance in understanding human immunodeficiency virus (HIV) biology was the discovery that the beta-chemokines MIP-1 alpha (macrophage inflammatory protein-1 alpha), MIP-1 beta (macrophage inflammatory protein-1 beta) and RANTES (regulated on activation, normal T-cell expressed and secreted) inhibit entry of HIV-1 into CD4+ cells by blocking the critical interaction between the CCR5 coreceptor and the V3 domain of the viral envelope glycoprotein gp120 [1,2]. CD8+ lymphocytes are a major source of beta-chemokines [3], but the stimulus for chemokine release has not been well defined. Here, we have shown that engagement of CD8+ cytotoxic T lymphocytes (CTLs) with HIV-1-encoded human leukocyte antigen (HLA) class I-restricted peptide antigens caused rapid and specific release of these beta-chemokines. This release paralleled cytolytic activity and could be attenuated by naturally occurring amino acid variation within the HLA class I-restricted peptide sequence. Epitope variants that bound to appropriate HLA class I molecules but failed to stimulate cytolytic activity in CTLs also failed to stimulate chemokine release. We conclude that signalling through the T-cell receptor (TCR) following binding of antigen results in beta-chemokine release from CTLs in addition to cytolytic activity, and that both responses can be abolished by epitope mutation. These results suggest that antigenic variation within HIV-1 might not only allow the host cell to escape lysis, but might also contribute to the propagation of infection by failing to activate beta-chemokine-mediated inhibition of HIV-1 entry.
first_indexed 2024-03-07T06:27:22Z
format Journal article
id oxford-uuid:f4c81f99-651f-47ff-ab8c-965eb60c33b7
institution University of Oxford
language English
last_indexed 2024-03-07T06:27:22Z
publishDate 1998
publisher Elsevier
record_format dspace
spelling oxford-uuid:f4c81f99-651f-47ff-ab8c-965eb60c33b72022-03-27T12:22:24ZAntigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f4c81f99-651f-47ff-ab8c-965eb60c33b7EnglishSymplectic Elements at OxfordElsevier1998Price, DSewell, ADong, TTan, RGoulder, PRowland-Jones, SPhillips, RA major advance in understanding human immunodeficiency virus (HIV) biology was the discovery that the beta-chemokines MIP-1 alpha (macrophage inflammatory protein-1 alpha), MIP-1 beta (macrophage inflammatory protein-1 beta) and RANTES (regulated on activation, normal T-cell expressed and secreted) inhibit entry of HIV-1 into CD4+ cells by blocking the critical interaction between the CCR5 coreceptor and the V3 domain of the viral envelope glycoprotein gp120 [1,2]. CD8+ lymphocytes are a major source of beta-chemokines [3], but the stimulus for chemokine release has not been well defined. Here, we have shown that engagement of CD8+ cytotoxic T lymphocytes (CTLs) with HIV-1-encoded human leukocyte antigen (HLA) class I-restricted peptide antigens caused rapid and specific release of these beta-chemokines. This release paralleled cytolytic activity and could be attenuated by naturally occurring amino acid variation within the HLA class I-restricted peptide sequence. Epitope variants that bound to appropriate HLA class I molecules but failed to stimulate cytolytic activity in CTLs also failed to stimulate chemokine release. We conclude that signalling through the T-cell receptor (TCR) following binding of antigen results in beta-chemokine release from CTLs in addition to cytolytic activity, and that both responses can be abolished by epitope mutation. These results suggest that antigenic variation within HIV-1 might not only allow the host cell to escape lysis, but might also contribute to the propagation of infection by failing to activate beta-chemokine-mediated inhibition of HIV-1 entry.
spellingShingle Price, D
Sewell, A
Dong, T
Tan, R
Goulder, P
Rowland-Jones, S
Phillips, R
Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title_full Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title_fullStr Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title_full_unstemmed Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title_short Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes.
title_sort antigen specific release of beta chemokines by anti hiv 1 cytotoxic t lymphocytes
work_keys_str_mv AT priced antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT sewella antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT dongt antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT tanr antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT goulderp antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT rowlandjoness antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes
AT phillipsr antigenspecificreleaseofbetachemokinesbyantihiv1cytotoxictlymphocytes